Toronto, February 28, 2020 - GMP Capital Inc. (GMP) (TSX: GMP) today reported revenue from continuing operations of $8.4 million in fourth quarter 2019; up 8% from $7.0 million reported in fourth quarter 2018. Net loss from continuing operations was $5.3 million in fourth quarter 2019 compared with net income of $1.1 million in fourth quarter 2018. The $6.4 million change from fourth quarter last year was due to several factors including $2.6 million in deferred tax asset recognized in fourth quarter 2018, a $1.8 million tax expense recorded in fourth quarter 2019 in connection with Part V1 tax relating to GMP's preferred shares, and $1.1 million in costs incurred this quarter to consolidate the ownership of Richardson GMP.
Revenue from continuing operations for the year ended 2019 was $36.8 million, up 18% compared with 2018. Net loss and diluted loss per share for the year ended 2019 from continuing operations was $13.7 million and $0.26, compared with a net loss of $2.4 million and a diluted loss per share of $0.10 in 2018. The $11.3 million increase in net loss is largely due to an $8.0 million non-cash write-down of deferred tax asset in 2019, $3.1 million ($2.8 million after-tax) in professional fees and restructuring costs related to consolidating the ownership of Richardson GMP, a $1.8 million tax expense recorded in fourth quarter 2019 in connection with Part V1 tax relating to GMP's preferred shares, partly offset by a net increase in stock borrowing and lending activity in 2019.
GMP CAPITAL INC. ENTERS INTO NON-BINDING TERM SHEET TO CONSOLIDATE OWNERSHIP OF RICHARDSON GMP
Toronto, February 26, 2020 - GMP Capital Inc. (“GMP” or the “Company”) (TSX: GMP) announced today that, based on the unanimous recommendation of an independent special committee (the “Special Committee”) of its board of directors (the “Board”) following an extensive review and analysis, it has entered into a non-binding term sheet with Richardson Financial Group Limited (“RFGL”) in respect of a transaction (the “RGMP Transaction”) to consolidate the ownership of Richardson GMP Limited (“Richardson GMP”). Pursuant to the terms of the RGMP Transaction, GMP will acquire all of the common shares of Richardson GMP that are not owned by the Company for a purchase price of two (2) common shares of GMP (the “Common Shares”) per common share of RGMP (“RGMP Common Share”). The RGMP Transaction will proceed pursuant to the terms of the Shareholders’ Agreement governing Richardson GMP (the “RGMP Shareholders’ Agreement”) and in connection therewith, contemporaneously with the execution of the non-binding term sheet, all three of Richardson GMP’s shareholder groups have jointly provided written notice to commence the liquidity mechanism process (the “RGMP Liquidity Mechanism”) under the RGMP Shareholders’Agreement.
Donald Wright, Chair of the Board and of the Special Committee commented, “Today’s announcement is the culmination of a strategic review process that resulted in the decision to make wealth management the centerpiece of the Company’s growth strategy. Consolidating the ownership of Richardson GMP is the natural next step to that end and will position the business for future success.”
“We are thrilled to have such a strong show of support from our partners at Richardson GMP. With their support we can confidently move to transform our company into a wealth management focused firm. Richardson GMP has the national scale, platform and services that will afford us the greatest opportunity to create long term value for our combined shareholders,” said Kish Kapoor, Interim President and CEO of GMP. “Our mission is to create the destination of choice for Canada’s top advisors who share our entrepreneurial spirit, independent culture and philosophy to deliver unparalleled face-to-face advice to affluent clients opting for non-bank points of access for holistic wealth management solutions. Powered by a strong balance sheet at the combined firms and the Richardson brand, which has a rich 90-year history of success in financial services, we are well positioned for an exciting period of growth in the company for generations to come,” added Kapoor.
Following an extensive review and analysis of the RGMP Transaction and other alternatives available to the Company, the Board (excluding conflicted directors, who did not participate in deliberations), having received the unanimous recommendation of the Special Committee, determined that the RGMP Transaction is in the best interests of GMP. The Board intends to recommend that GMP’s shareholders (other than RFGL) vote in favour of the RGMP Transaction at a special meeting of shareholders to be held to approve the RGMP Transaction (the “Special Meeting”).
In connection with its review, the Special Committee retained RBC Capital Markets (“RBC”) to prepare a formal valuation of the RGMP Common Shares (the “RGMP Valuation”) and of the Common Shares (the “Common Share Valuation”) to be issued by the Company pursuant to the RGMP Transaction (the “GMP Consideration”) as required under Multilateral Instrument 61- 101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). RBC concluded that, as of February 25, 2020, and subject to the assumptions, limitations and qualifications as set out in the RGMP Valuation, that the value of the RGMP Common Shares on an en bloc basis was in the range of $4.25 to $5.15 per share, which represents a total equity value of the RGMP Common Shares of $355 million to $430 million. As part of the RGMP Valuation, RBC included the after tax, net present value impact of $36 million in retention-related bonuses as described further below. RBC also concluded that, as of February 25, 2020, and subject to the assumptions, limitations and qualifications as set out in the Common Share Valuation, the value of the Common Shares on an en bloc basis was in the range of $2.20 to $2.90 per share. A significant portion of the Common Share Valuation was directly derived from the RGMP Valuation given the Company’s ownership interest in Richardson GMP. RBC has also provided its opinion (the “Fairness Opinion”) to the Special Committee and the Board that, as of February 25, 2020, and subject to the assumptions, limitations and qualifications contained therein, the GMP Consideration to be paid by the Company pursuant to the RGMP Transaction is fair, from a financial point of view, to the Company
The conclusions and recommendations of the Special Committee and the Board have been based on a number of factors, including the following:
Pursuant to the terms of the RGMP Transaction, GMP will acquire all of the RGMP Common Shares that are not owned by the Company for a purchase price of two (2) Common Shares per RGMP Common Share. In negotiating the RGMP Transaction, the Special Committee and RFGL mutually agreed to use $5.14 and $2.57 per share as reference values for the RGMP Common Shares and Common Shares, respectively. It is expected that the Company will issue to shareholders of Richardson GMP an aggregate of approximately 110.994 million Common Shares (the “Consideration Shares”). Upon closing of the RGMP Transaction, 10% of the Consideration Shares will be paid to Richardson GMP’s shareholders and the remaining 90% will be placed in escrow to be released in equal amounts on the first, second and third anniversaries of the closing subject to the satisfaction of certain conditions. The Consideration Shares will also be subject to downward adjustment if investor advisor departures over the first year following closing exceed a certain threshold, measured on the AUA associated with those investments advisors as of the closing date.
After giving effect to the RGMP Transaction, if completed, the Company will have an estimated 186.428 million Common Shares issued and outstanding. RFGL, GMP’s largest shareholder with an aggregate ownership stake of approximately 24.1% of Common Shares immediately prior to the RGMP Transaction, will have an estimated aggregate ownership position of approximately 39.7% following completion of the RGMP Transaction. Existing GMP shareholders (other than RFGL) and Richardson GMP investment advisors will hold 30.7% and 29.6%, respectively, of the Common Shares following completion of the RGMP Transaction.
Hartley Richardson, President and Chief Executive Officer of James Richardson & Sons, Limited added, “We are very pleased with this opportunity to reinforce and renew our long-term commitment to Richardson GMP, and to provide our expertise, reputation, and brand as we continue to build a firm that serves the complete wealth management needs of Canadian families. We fully support the transaction to make Richardson GMP the engine for future growth in value for GMP shareholders. We also believe that GMP’s exclusive focus on wealth management will be of great benefit to Richardson GMP’s highly valued clients, investment advisors, management and employees.”
Pursuant to the RGMP Transaction, GMP will also purchase for cash all of the preferred shares in the capital of Richardson GMP held by RFGL in consideration for a payment equal to the redemption price of such preferred shares, together with all accrued but unpaid dividends, and will purchase for cash outstanding indebtedness of current investment advisors and other employees of Richardson GMP and their affiliated entities and their related employees owing to RFGL and its affiliates for the aggregate principal amount thereof, together with all accrued but unpaid interest thereon.
Upon successful completion of the RGMP Transaction, RGMP intends to allocate $36 million toward a retention plan award program for existing investment advisors.
“Marc Dalpe and Neil Bosch, the two elected investment advisors representatives on the board of Richardson GMP, with the strong support of our fellow shareholders in Richardson GMP, joined me in fully endorsing the proposed transaction at our nationally broadcast town hall meeting from Calgary following the close of markets last evening,” said Andrew Marsh, President and Chief Executive Officer of Richardson GMP. “We believe this transaction affords our advisors, who are amongst the best in the country, and the growing number looking to join us, the best opportunity to serve the unique wealth management needs of high net worth families across Canada."
Richardson GMP investment advisors, collectively representing over 75% of Richardson GMP’s assets under administration, have already indicated their support for the RGMP Transaction by entering into acknowledgment and support letters. More are expected to support the RGMP Transaction over the next few days as the leadership team reaches out to those who were unable to attend the event last night.
Name Changes – at GMP and Richardson GMP
In the coming months, both GMP and Richardson GMP will change their corporate names to one that will be more aligned with the Richardson brand and the go-forward wealth management strategy of the Company.
Richardson GMP Liquidity Mechanism Details
The RGMP Transaction will proceed pursuant to the terms of the RGMP Shareholders’ Agreement and, in connection therewith, contemporaneously with the execution of the non-binding term sheet all three of Richardson GMP’s shareholder groups have jointly provided written notice to commence the RGMP Liquidity Mechanism. Shortly following a contractual 15 business day notice period under the RGMP Liquidity Mechanism, GMP and RFGL intend to enter into a definitive agreement for the RGMP Transaction, which will enable GMP to acquire all of the RGMP Common Shares it does not already own.
The material aspects of the RGMP Liquidity Mechanism can be found in GMP’s most recent annual information form, which is available on the SEDAR profile of GMP at www.sedar.com.
In anticipation of the execution of the definitive agreement for the RGMP Transaction, GMP has called a special meeting of common shareholders for April 21, 2020, to approve the RGMP Transaction in accordance with applicable Toronto Stock Exchange and securities rules.
The RGMP Transaction is expected to close in the second quarter of 2020, subject to shareholder and regulatory approvals and other customary closing conditions. The terms and conditions of the RGMP Transaction will be disclosed in greater detail in a management information circular for the Special Meeting that is expected to be mailed to GMP’s shareholders shortly following the execution of the definitive agreement for the RGMP Transaction. Copies of the definitive agreement and of the management information circular for the Special Meeting will be filed with Canadian securities regulators and will be available on the SEDAR profile of GMP at www.sedar.com. Shareholders are urged to read those and other relevant materials when they become available.
There can be no assurance that GMP and RFGL will enter into a definitive agreement for the RGMP Transaction or that the RGMP Transaction will occur as proposed or at all.
Non-GAAP Measures We use certain measures to assess our financial performance that are not generally accepted accounting principles (“GAAP”) measures under International Financial Reporting Standards (“IFRS”). These measures do not have any standardized meaning prescribed by GAAP and are therefore unlikely to be comparable to similar measures presented by other issuers. Non-GAAP measures should not be considered as alternatives to net income or comparable metrics determined in accordance with IFRS as indicators of GMP’s performance, liquidity, cash flows, and profitability.
Assets Under Administration
Assets under administration (“AUA”) is a non-GAAP financial measure of client assets that are common to the wealth management business. AUA represents the market value of client assets managed and administered by the Company from which the Company earns commissions and fees. This measure includes funds held in client accounts as well as the aggregate market value of long and short security positions. The Company’s method of calculating may differ from the methods used by other companies and therefore may not be comparable to other companies. Management uses these measures to assess Richardson GMP’s operational performance.
Financial statement items that exclude significant items are non-GAAP measures under IFRS. Management believes adjusting certain results and measures by excluding the impact of specified items may be more reflective of ongoing operating results and provides readers with an enhanced understanding of how management views GMP’s and Richardson GMP’s core performance. Management assesses performance on both a reported and an adjusted basis and considers both bases to be useful in assessing underlying, ongoing business performance. Presenting results on both bases also permits readers to assess the impact of the specified items on the results for the periods presented.
Richardson GMP presents earnings before interest, income tax, depreciation and amortization (EBITDA) which excludes:
Richardson GMP also presents an adjusted EBITDA which excludes the following (“adjusted EBITDA”):
EBITDA and adjusted EBITDA do not have any standardized meaning prescribed by GAAP and are therefore unlikely to be comparable to similar measures presented by other issuers. These non-GAAP measures should not be considered as alternatives to net income or comparable metrics determined in accordance with IFRS as indicators of Richardson GMP’s performance, liquidity, cash flows, and profitability. Richardson GMP’s management believes adjusting results by excluding the impact of the specified items is more reflective of ongoing financial performance and cash generating capabilities and provides readers with an enhanced understanding of how management views Richardson GMP’s core performance.
This press release contains “forward-looking information” as defined under applicable Canadian securities laws. This information includes, but is not limited to, statements concerning our objectives, our strategies to achieve those objectives, as well as statements made with respect to management’s beliefs, plans, estimates, projections and intentions, and similar statements concerning anticipated future events, results, circumstances, performance or expectations that are not historical facts. Forward-looking information generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking information reflects management’s current beliefs and is based on information currently available to management. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement.
The forward-looking statements included in this press release, including statements regarding the RGMP Transaction, the nature of GMP’s growth strategy going forward and execution of any of its potential plans, are not guarantees of future results and involve numerous risks and uncertainties that may cause actual results to differ materially from the potential results discussed in the forward-looking statements. In respect of the forward-looking statements and information concerning the consolidation of 100% of ownership in Richardson GMP, and the Company’s strategy going forward, management has provided same based on reliance on certain assumptions it considers reasonable at this time including that a transaction involving Richardson GMP can be completed on acceptable terms and that any conditions precedent can be satisfied. There is no assurance that any transaction involving Richardson GMP will result from the discussions with RFGL or on what terms or structure any transaction may occur as proposed or at all, including the timing of the completion of any transaction involving Richardson GMP. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release.
Risks and uncertainties related to the RGMP Transaction include, but are not limited to: failure of GMP and RFGL to enter into the RGMP Transaction on satisfactory terms, or at all; failure of GMP and RFGL to obtain the required shareholders and regulatory approvals for, or satisfy other conditions to effect, the RGMP Transaction; the risk that the RGMP Transaction may involve unexpected costs, liabilities or delays; the risk that, prior to or as a result of the completion of the RGMP Transaction, the business of GMP and/or Richardson GMP may experience significant disruptions, including loss of clients or employees due to transaction related uncertainty, industry conditions or other factors; risks relating to employee retention; the risk that legal proceedings may be instituted against GMP or Richardson GMP; and risks related to the diversion of management’s attention from GMP’s ongoing business operations. For a description of additional risks that could cause our actual results to materially differ from our current expectations, see the “Risk Management” and “Risk Factors” sections of GMP’s most recent Annual MD&A and the “Risk Factors” section in the Company’s AIF. For additional information on the risk factors related to the RGMP Transaction, see “The Sale Transaction – Reasons for the Sale Transaction” and “The Sale Transaction – Risk Factors” in GMP’s Notice of Special Meeting and Management Information Circular dated July 8, 2019 (the “July 2019 Circular”). Material assumptions and factors underlying the forward-looking information in this press release include, but are not limited to, those set out in “Business Environment – Outlook” in GMP’s most recent Annual MD&A. GMP’s most recent Annual MD&A and July 2019 Circular are filed under the Corporation’s profile on SEDAR at www.sedar.com.
Although forward-looking information contained in this press release is provided based on management’s reliance on certain assumptions it considers reasonable, there can be no assurance that such expectations will prove to be correct. Certain statements included in this press release may be considered a “financial outlook” for purposes of applicable Canadian securities laws, and as such, the financial outlook may not be appropriate for purposes other than this press release. Readers should not place undue reliance on the forward-looking statements and information contained in this press release. When relying on forward-looking statements to make decisions, readers should carefully consider the foregoing factors, the list of which is not exhaustive.
The forward-looking information contained in this press release is made as of the date of this press release, and should not be relied upon as representing GMP’s views as of any date subsequent to the date of this press release. Except as required by applicable law, Management and the Board undertake no obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
ABOUT GMP CAPITAL INC.
For further information please contact: GMP Capital Inc. Rocco Colella, Director, Investor Relations 145 King Street West, Suite 200, Toronto, Ontario M5H 1J8 Tel: (416) 941-0894; Fax: (416) 943-6175 firstname.lastname@example.org or email@example.com
TORONTO, ON. (February 6, 2020) – GMP Capital Inc. (GMP) (TSX:GMP) will release its fourth quarter and fiscal 2019 financial results and host an earnings conference call on Friday, February 28, 2020. Financial results are expected to be released at approximately 6:00 a.m. (EST).